Navigation Links
Phlo Affiliate Names Director Of Marketing
Date:11/7/2007

JACKSONVILLE, Fla., Nov. 7 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the "Company") announced today that it has hired Dan Reynolds as its Director of Marketing. Mr. Reynolds is a marketing and communications expert with nearly 30 years of experience in the United States and Canada. Mr. Reynolds will support the branding, marketing, and communications functions of the Company, headed by Rudy Prajza, Chief Marketing Officer.

Mr. Reynolds' professional experience includes work in over 14 industries such as food and beverages, financial services, hospitality, telecommunications, automobiles, health and beauty aids, and petroleum. His direct working experience includes such internationally-recognized organizations as Gillette, Subway, Sears, Royal Bank, BMW, Honda, the Government of Canada, Brita (water purifiers), and Petro-Canada, among others.

Mr. Reynolds has worked with a number of marketing communications companies including Saatchi & Saatchi, DMB&B, Foote, Cone & Belding, and MacLaren-McCann Advertising.

AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein
'/>"/>

SOURCE Phlo Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Phlo Affiliate Reports Expanded Coverage to Oregon Border
2. Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores
3. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
4. Phlo Affiliate to Launch AQUISS(TM) on East Coast
5. KGI Names Kerry Howell Vice President for Advancement
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. CryoLife Names Philip Theodore as Vice President, General Counsel
10. Genstar Names Michael Hurt to Its Strategic Advisory Board
11. PPD Names Daniel Darazsdi as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the ... efforts of True Green Energy Group and True Green Planet,s ... the recycling business for over 25 years, stated that Spectrum ... setting the stage for spectacular earnings because of the bi ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Carbondioxide Incubators - A ... ,, Incubators are the most ... research, and other applications for providing a ...
(Date:12/2/2009)... research executives, scientists, policy makers, and funders today convened ... at the inaugural Partnering for Cures meeting. ... the Milken Institute, convened Partnering for Cures ... discovery into an accessible therapy. This effort unites ...
(Date:12/2/2009)... (Nasdaq: PPHM ) today reported completion of patient ... Cotara® in patients with relapsed glioblastoma multiforme (GBM), the ... targeted monoclonal antibody linked to a radioisotope being developed ... specifically targets cells at the center of brain tumors, ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... an acceptable primary endpoint, for a ... 28 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... an agreement with the U.S. Food and Drug Administration ... registration trial of OGX-011, its lead product candidate targeting ...
... S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 ... Treatment of Epilepsy Patients With Partial Onset,Seizures , ... do Coronado, Portugal, President &,CEO Dr Luis Portela), and ... European subsidiary of Eisai Co., Ltd. (Tokyo, President &,CEO: ...
... -- Encorium Group, Inc. (Nasdaq: ... organization (CRO) that provides design, development, and management ... many of the world,s leading pharmaceutical companies, today ... Second Annual Vaccine Industry Excellence Award for Best ...
Other Biology Technology:OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 2OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 3OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 4OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 5OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 6Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 2Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 3Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 4Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 5Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 6Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 7Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 8Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 9Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 2Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 3Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 4
(Date:12/3/2009)... Now in its 32nd year, the CTRC-AACR San ... in breast cancer science and world leaders from industry ... , This year, more than 8,500 scientists and ... Convention Center in San Antonio from Dec. 9-13, 2009. ...
(Date:12/3/2009)... must be included in the design of the upcoming forest ... according to a scientist at the University of Leeds. ... argues that at least 50% of the carbon credit payments ... from Deforestation and Degredation), should be made to forest dwellers ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 1New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 3Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 1Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 2Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 3
... announced Quebec's first successful combined heart/liver transplant. The patient, ... Institut de cardiologie de Quebec (l'hôpital Laval) to the ... during a 6-hour operation on April 14, 2006 and ... 15 physicians, surgeons and other health care professionals. The ...
... new machine ?the only one of its kind in Australia ... babies. , Scientists at the Monash Institute of Medical Research ... blood pressure and the amount of oxygen in a preterm ... pressure, which reduces the oxygen supply to their brain," said ...
... particularly prone to global warming caused by industrial and ... Now, a University of Utah study finds a surprising ... Arctic's well-known haze ?made of particulate pollution from mid-latitude ... to trap heat. , The effect makes the Arctic ...
Other Biology News:MUHC announces a transplant first in Quebec 2Research offers new hope for preterm babies 2Pollutant haze heats the Arctic 2Pollutant haze heats the Arctic 3Pollutant haze heats the Arctic 4
... Standard Bio for vacuum concentrator/centrifugal evaporator ... biology and biochemistry for rapid and safe ... can be expanded with pumps, different of ... rotors (eliminating sample loss by transfer), ensuring ...
...
... Start up kit. Includes configured Laptop PC ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Biology Products: